North Landing Financial Partners, LLC Bristol Myers Squibb CO Transaction History

North Landing Financial Partners, LLC

  • $590 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023
BUY
$65.71 - $74.53 $985 - $1,117
15 Added 0.11%
13,564 $940,000
Q4 2022

Feb 03, 2023
BUY
$68.48 - $81.09 $8,491 - $10,055
124 Added 0.92%
13,549 $974,000
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $1,745 - $1.03 Million
13,425 New
13,425 $954,000

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track North Landing Financial Partners, LLC Portfolio

Follow North Landing Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Landing Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Landing Financial Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email